Your session is about to expire
← Back to Search
Device
Finger Movement Training for Stroke
N/A
Recruiting
Research Sponsored by North Carolina State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change of value from before the intervention to immediately after the intervention.
Awards & highlights
No Placebo-Only Group
Summary
This trial will assess a new rehab intervention combining electrical stimulation + soft exoskeleton to improve hand function after stroke.
Who is the study for?
This trial is for stroke survivors who are 2-6 months post-stroke, can consent, see shapes on a screen, and have moderate to mild hand impairment without severe pain or joint issues that would prevent movement.
What is being tested?
The study tests a new therapy combining electrical nerve stimulation with a soft hand exoskeleton (AVK system) to improve finger movement. Participants will undergo 15 training sessions over 5 weeks with evaluations before, during, after training, and one month later.
What are the potential side effects?
Potential side effects may include discomfort from the electrical stimulation or exoskeleton use. Muscle fatigue and soreness could occur due to repetitive movements during the training sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change of value from before the intervention to immediately after the intervention.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change of value from before the intervention to immediately after the intervention.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change of Jebsen-Taylor Hand Function Test (JTHFT)
Secondary study objectives
Change of 3-point pinch strength
Change of 9-Hole Peg Test (9PHT)
Change of Box and Blocks Test (BBT)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Functional electrical stimulation (FES) + AVK groupExperimental Treatment1 Intervention
This group will use the AVK system in combination with targeted FES to provide training of independent movement of each digit of the paretic hand. This training has two modes: Key Combination and Song. In the Key Combination mode, the subject will attempt to play the discrete key or key combinations specified on the computer screen to practice difficult movements and combinations. In the Song mode, sequential, rhythmic movements will be practiced as the participant is guided to play a series of keys, specified as falling keys, constituting five-note songs. Key Combination will be employed at the beginning and end of each training session to practice discrete movements that proved troubling during the current or previous session. Most of the session will be spent in the Song mode to emphasize the transitions from one movement to the next. In both modes the AVK system will trigger FES for the finger matching the desired key and signal the PneuGlove to resist movement of other digits.
Group II: OT GroupActive Control1 Intervention
An occupational therapist will provide therapy of matching duration to the OT subject group. This will consist of 10 minutes of stretching of the finger muscles, particularly of the extrinsic finger flexors. This stretching will be followed by two 20-minute sessions of therapy focused on active task practice, object manipulation, and individuated movement of the digits. The Canadian Occupational Performance Measure (COPM) will be administered to identify goals that incorporate dexterous use of the paretic hand. Part of each training session will be used to practice these tasks, while the remainder will be used to practice component skills. Active practice will be followed by a final 10 minutes of stretching of muscles of the digits.
Find a Location
Who is running the clinical trial?
North Carolina State UniversityLead Sponsor
35 Previous Clinical Trials
13,974 Total Patients Enrolled
5 Trials studying Stroke
268 Patients Enrolled for Stroke
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,068 Previous Clinical Trials
2,747,508 Total Patients Enrolled
86 Trials studying Stroke
5,817 Patients Enrolled for Stroke